Loading organizations...
Developing first-in-class therapies to modulate gene expression.
Cellestia has raised $28.4M across 2 funding rounds.
Cellestia has raised $28.4M in total across 2 funding rounds.
Cellestia has raised $28.4M in total across 2 funding rounds.
Cellestia's investors include Fontus Capital, Partners Investment, PPF Group, Jens Hennecke.
Cellestia has raised $28.4M across 2 funding rounds. Most recently, it raised $20.4M Series B in December 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 17, 2019 | $20.4M Series B | Fontus Capital, Partners Investment, PPF Group | |
| Jan 27, 2017 | $8.0M Seed | Jens Hennecke |